High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.

Carolin CzaudernaIrene SchmidtmannSandra KochLukas PilzSophia HeinrichGerd OttoJens MittlerHauke LangRoman KloecknerChristoph DüberMartin F SprinzlMarcus A WörnsPeter R GalleJens U MarquardtArndt Weinmann

Published in: United European gastroenterology journal (2020)

Static and dynamic alpha-fetoprotein variables prior to therapy are predictive for overall survival of hepatocellular carcinoma patients. Addition of AFP-slope to established prognostic parameters might improve prognostic classification for a subgroup of hepatocellular carcinoma patients with preserved liver function and without portal vein tumour thrombosis.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
deep learning
pulmonary embolism
free survival
stem cells
clinical trial
randomized controlled trial
patient reported outcomes
mesenchymal stem cells
study protocol